XENE
Price:
$44.61
Market Cap:
$3.45B
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopa...[Read more]
Industry
Biotechnology
IPO Date
2014-11-05
Stock Exchange
NASDAQ
Ticker
XENE
According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -38.50%. This represents a change of 293.14% compared to the average of -9.79% of the last 4 quarters.
The mean historical ROE of Xenon Pharmaceuticals Inc. over the last ten years is -32.51%. The current -38.50% ROE has changed 18.42% with respect to the historical average. Over the past ten years (40 quarters), XENE's ROE was at its highest in in the June 2020 quarter at -0.09%. The ROE was at its lowest in in the December 2017 quarter at -22.44%.
Average
-32.51%
Median
-28.42%
Minimum
-85.45%
Maximum
-14.34%
Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 137.42%
Maximum Annual ROE = -14.34%
Minimum Annual Increase = -244.29%
Minimum Annual ROE = -85.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | -31.04% | 57.92% |
| 2023 | -19.66% | 13.12% |
| 2022 | -17.38% | 21.17% |
| 2021 | -14.34% | -14.78% |
| 2020 | -16.83% | -62.79% |
| 2019 | -45.22% | 35.41% |
| 2018 | -33.40% | -60.91% |
| 2017 | -85.45% | 137.42% |
| 2016 | -35.99% | 39.44% |
| 2015 | -25.81% | -244.29% |
The current ROE of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.69%
5-year avg
-19.85%
10-year avg
-32.51%
Xenon Pharmaceuticals Inc.’s ROE is greater than Centessa Pharmaceuticals plc (-56.47%), greater than Apogee Therapeutics, Inc. (-34.98%), greater than ASCENTAGE PHARMA GROUP INTERNATIONAL (-249.24%), greater than Ultragenyx Pharmaceutical Inc. (-414.17%), greater than Celcuity Inc. (-179.00%), greater than Zai Lab Limited (-27.32%), greater than CG Oncology, Inc. Common stock (-15.40%), greater than Scholar Rock Holding Corporation (-121.95%), greater than Travere Therapeutics, Inc. (-178.68%), greater than Legend Biotech Corporation (-30.95%),
| Company | ROE | Market cap |
|---|---|---|
| -56.47% | $3.97B | |
| -34.98% | $4.14B | |
| -249.24% | $2.85B | |
| -414.17% | $3.52B | |
| -179.00% | $4.90B | |
| -27.32% | $2.21B | |
| -15.40% | $3.35B | |
| -121.95% | $4.61B | |
| -178.68% | $3.16B | |
| -30.95% | $2.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Xenon Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Xenon Pharmaceuticals Inc. (XENE)?
What is the highest ROE for Xenon Pharmaceuticals Inc. (XENE)?
What is the 3-year average ROE for Xenon Pharmaceuticals Inc. (XENE)?
What is the 5-year average ROE for Xenon Pharmaceuticals Inc. (XENE)?
How does the current ROE for Xenon Pharmaceuticals Inc. (XENE) compare to its historical average?